Home
/
DNA X, Inc.
/
Financials
/
Quarterly
DNA X, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that DNA X, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$16.21M
Oct 31, 2025
Q2
2025
Jun 30, 2025
$11.19M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$16.72M
May 12, 2025
Q3
2025
Sep 30, 2024
$15.02M
Oct 31, 2025
Q3
2024
Jun 30, 2024
$28.29M
Nov 13, 2024
Q2
2025
Jun 30, 2024
$11.52M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$16.78M
May 12, 2025
Q3
2024
Mar 31, 2024
$16.78M
Nov 13, 2024
Q3
2024
Sep 30, 2023
$27.57M
Nov 13, 2024
Q3
2019
Sep 30, 2019
$28.85M
Nov 12, 2019
Q2
2019
Jun 30, 2019
$43.75M
Aug 13, 2019
Q1
2019
Mar 31, 2019
$26.48M
Jun 24, 2019
Q3
2019
Sep 30, 2018
$39.50M
Nov 12, 2019
Q2
2019
Jun 30, 2018
$31.45M
Aug 13, 2019
Q1
2019
Mar 31, 2018
$18.19M
Jun 24, 2019
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$16.21M
Oct 31, 2025
Q2
2025
Jun 30, 2025
$11.19M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$16.72M
May 12, 2025
Q3
2025
Sep 30, 2024
$15.02M
Oct 31, 2025
Q2
2025
Jun 30, 2024
$11.52M
Aug 8, 2025
Q3
2024
Jun 30, 2024
$20.63M
Nov 13, 2024
Q1
2025
Mar 31, 2024
$9.12M
May 12, 2025
Q3
2024
Mar 31, 2024
$9.12M
Nov 13, 2024
Q3
2024
Sep 30, 2023
$27.57M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$26.84M
Aug 9, 2024
Q1
2024
Mar 31, 2023
$25.80M
May 14, 2024
Q3
2023
Sep 30, 2022
$20.50M
Nov 14, 2023
Q2
2023
Jun 30, 2022
$11.96M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$13.26M
May 8, 2023
Q3
2022
Sep 30, 2021
$14.45M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$11.95M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$12.24M
May 10, 2022
Q3
2021
Sep 30, 2020
$14.39M
Jun 29, 2022
Q2
2021
Jun 30, 2020
$21.06M
Jun 29, 2022
Q1
2021
Mar 31, 2020
$12.71M
May 11, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.75M)
Oct 31, 2025
Q2
2025
Jun 30, 2025
($7.48M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
$458.0K
May 12, 2025
Q3
2025
Sep 30, 2024
($2.51M)
Oct 31, 2025
Q2
2025
Jun 30, 2024
($6.62M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($2.91M)
May 12, 2025
Q3
2024
Sep 30, 2023
$527.0K
Nov 13, 2024
Q2
2024
Jun 30, 2023
$509.0K
Aug 9, 2024
Q1
2024
Mar 31, 2023
$227.0K
May 14, 2024
Q3
2023
Sep 30, 2022
($1.61M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($4.23M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($7.21M)
May 8, 2023
Q3
2022
Sep 30, 2021
($10.94M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($6.69M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($9.28M)
May 10, 2022
Q3
2021
Sep 30, 2020
($6.46M)
Jun 29, 2022
Q2
2021
Jun 30, 2020
($7.10M)
Jun 29, 2022
Q1
2021
Mar 31, 2020
($9.96M)
May 11, 2021
Q3
2020
Sep 30, 2019
($6.78M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($5.60M)
Aug 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.98M)
Oct 31, 2025
Q2
2025
Jun 30, 2025
($6.73M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
$645.0K
May 12, 2025
Q3
2025
Sep 30, 2024
($2.38M)
Oct 31, 2025
Q2
2025
Jun 30, 2024
($6.47M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($2.69M)
May 12, 2025
Q3
2024
Sep 30, 2023
$688.0K
Nov 13, 2024
Q2
2024
Jun 30, 2023
$747.0K
Aug 9, 2024
Q1
2024
Mar 31, 2023
$333.0K
May 14, 2024
Q3
2023
Sep 30, 2022
($1.93M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($4.22M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($7.08M)
May 8, 2023
Q3
2022
Sep 30, 2021
($10.72M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($6.49M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
($9.05M)
May 10, 2022
Q3
2021
Sep 30, 2020
($6.12M)
Jun 29, 2022
Q2
2021
Jun 30, 2020
($6.62M)
Jun 29, 2022
Q1
2021
Mar 31, 2020
($9.06M)
May 11, 2021
Q3
2020
Sep 30, 2019
($6.26M)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($4.58M)
Aug 12, 2020